Semi-Annual Consolidated Statement Of Comprehensive Income

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-305,856,000 JPY
-344,145,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.